Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer

NCT03429192 is registered in ClinicalTrials.gov with Tianjin Chest Hospital as lead sponsor.

NCT NCT03429192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03429192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
Lead sponsor
Tianjin Chest Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
March 30, 2018
Enrollment
2,653 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer